Matthew Plunkett
2017 - CTI BioPharma
In 2017, Matthew Plunkett earned a total compensation of $743.2K as Former Executive Vice President, Chief Business Officer at CTI BioPharma, a 49% increase compared to previous year.
Compensation breakdown
| Option Awards | $177,378 |
|---|---|
| Salary | $283,199 |
| Other | $282,634 |
| Total | $743,211 |
Plunkett received $283.2K in salary, accounting for 38% of the total pay in 2017.
Plunkett also received $177.4K in option awards and $282.6K in other compensation.
Rankings
In 2017, Matthew Plunkett's compensation ranked 10,341st out of 14,666 executives tracked by ExecPay. In other words, Plunkett earned more than 29.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,341 out of 14,666 | 30th |
Division Manufacturing | 4,007 out of 5,768 | 31st |
Major group Chemicals And Allied Products | 1,412 out of 2,074 | 32nd |
Industry group Drugs | 1,148 out of 1,730 | 34th |
Industry Pharmaceutical Preparations | 896 out of 1,329 | 33rd |
Source: SEC filing on March 30, 2018.
Plunkett's colleagues
We found six more compensation records of executives who worked with Matthew Plunkett at CTI BioPharma in 2017.
2017
Adam Craig
CTI BioPharma
Chief Executive Officer
2017
Bruce Seeley
CTI BioPharma
Chief Operating Officer
2017
Jack Singer
CTI BioPharma
Chief Scientific Officer
2017
David Kirske
CTI BioPharma
Chief Financial Officer
2017
Louis Bianco
CTI BioPharma
Former Executive Vice President, Finance and Administration
2017
Richard Love
CTI BioPharma